Page last updated: 2024-08-17

quinoxalines and naloxone

quinoxalines has been researched along with naloxone in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.13)18.7374
1990's14 (43.75)18.2507
2000's12 (37.50)29.6817
2010's4 (12.50)24.3611
2020's1 (3.13)2.80

Authors

AuthorsStudies
Slavik, KJ; Szilagyi, JE2
Pinnock, RD1
Inokuchi, H; Nishi, S; Polosa, C; Trzebski, A; Yoshimura, M1
Harrison, NL; Lambert, NA; Teyler, TJ1
Christie, MJ; Miyake, M; North, RA1
Lester, BR; Sun, Z; Wilcox, GL; Wu, HH1
Birnbaum, AK; Law, PY; Wilcox, GL; Wotta, DR1
Calvo, P; Fernández-López, A; Gómez, T; Revilla, V; Soria, C1
Nicoll, RA; Weisskopf, MG; Zalutsky, RA1
Cappendijk, SL; de Vries, R; Dzoljic, MR1
Beani, L; Bianchi, C; Borea, PA; Simonato, M; Varani, K1
Keana, JF; Kwon, IS; Lutfy, K; Marek, P; Sadowski, B; Weber, E1
Chieng, B; Christie, MJ; Connor, M1
Gruol, DL; Netzeband, JG; Parsons, KL; Przewlocki, R; Siggins, GR; Sweeney, DD; Trotter, C1
Hall, SR; Jhamandas, K; Milne, B; Sullivan, ME1
Sztajnbok, J1
García-Barrado, MJ; Iglesias-Osma, MC; Martín, M; Moratinos, J; Rodríguez, R1
Kratzer, U; Schmidt, WJ1
Wang, HL; Wang, HS; Wu, WR; Xiang, XH; Zhao, Y1
Castañeda-Hernández, G; Granados-Soto, V; Lozano-Cuenca, J1
Grandoso, L; Pineda, J; Torrecilla, M; Ugedo, L1
Cao, DY; Guo, Y; Wang, HL; Wang, HS; Wu, WR; Xiang, XH; Zhao, Y1
Aase, DM; Atkinson, DM; Gewirtz, JC; Harris, AC1
Brock, SC; Tonussi, CR1
Cunha, FQ; Duarte, DB; Ferrari, LF; Ferreira, SH; Funez, MI; Lorenzetti, BB; Parada, CA; Sachs, D1
Huntington, N; Lai Becker, M; Woolf, AD1
Castro, RR; Cunha, FQ; Girão, VC; Leite, AC; Leite, AK; Rocha, FA; Silva, FS1
Cervantes-Durán, C; Espinosa de los Monteros-Zuñiga, A; Godínez-Chaparro, B; Izquierdo, T; Lozada, MC1
Cervantes-Durán, C; Granados-Soto, V; Murbartián, J; Quiñonez-Bastidas, GN; Rocha-González, HI1
Asatryan, A; Geoffroy, P; Kort, J; Kosloski, MP; Liu, W; Zhao, W1
Chambers, A; Cumpston, KL; Kershner, E; Tobarran, N; Wills, BK1

Trials

1 trial(s) available for quinoxalines and naloxone

ArticleYear
No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:10

    Topics: Adult; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cyclopropanes; Drug Interactions; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Male; Methadone; Middle Aged; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Proline; Protease Inhibitors; Pyrrolidines; Quinoxalines; Sulfonamides; Surveys and Questionnaires; Young Adult

2017

Other Studies

31 other study(ies) available for quinoxalines and naloxone

ArticleYear
Naloxone-induced bradycardia in pithed rats: evidence for an interaction with the peripheral sympathetic nervous system and alpha-2 adrenoceptors.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:3

    Topics: Animals; Atropine; Brimonidine Tartrate; Decerebrate State; Dose-Response Relationship, Drug; Heart Rate; Male; Methacholine Chloride; Naloxone; Phentolamine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Sympathetic Nervous System

1992
Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro.
    Brain research, 1992, Jun-26, Volume: 583, Issue:1-2

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Afferent Pathways; Animals; Benzofurans; Bicuculline; Bombesin; Cholecystokinin; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Evoked Potentials; Glutamates; Glutamic Acid; In Vitro Techniques; Kynurenic Acid; N-Methylaspartate; Naloxone; Naltrexone; Neurons; Picrotoxin; Prazosin; Pyrrolidines; Quinoxalines; Raphe Nuclei; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serotonin; Synapses; Tetrodotoxin

1992
Fast inhibitory postsynaptic potentials and responses to inhibitory amino acids of sympathetic preganglionic neurons in the adult cat.
    Journal of the autonomic nervous system, 1992, Volume: 41, Issue:1-2

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Animals; Atropine; Bicuculline; Cats; gamma-Aminobutyric Acid; Ganglia, Sympathetic; Glycine; Membrane Potentials; Naloxone; Neurons; Phentolamine; Quinoxalines; Spinal Cord; Strychnine; Synapses

1992
Evidence for mu opiate receptors on inhibitory terminals in area CA1 of rat hippocampus.
    Neuroscience letters, 1991, Mar-11, Volume: 124, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Barium; Bicuculline; Dendrites; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hippocampus; Ion Channel Gating; Naloxone; Nerve Endings; Potassium Channels; Quinoxalines; Rats; Receptors, GABA-A; Receptors, Opioid; Receptors, Opioid, mu

1991
Single potassium channels opened by opioids in rat locus ceruleus neurons.
    Proceedings of the National Academy of Sciences of the United States of America, 1989, Volume: 86, Issue:9

    Topics: Action Potentials; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Brimonidine Tartrate; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Electric Conductivity; Endorphins; Enkephalin, Methionine; Locus Coeruleus; Membrane Potentials; Naloxone; Neurons; Potassium Channels; Quinoxalines; Rats; Receptors, Adrenergic, alpha; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Opioid, mu; Receptors, Somatostatin; Somatostatin

1989
Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord.
    Pain, 1994, Volume: 56, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Catecholamines; Cell Transplantation; Desipramine; Dioxanes; Idazoxan; Injections, Spinal; Male; Melanoma, Experimental; Mice; Mice, Inbred ICR; Morphine; Naloxone; Neoplasm Transplantation; Nociceptors; Pain Threshold; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Spinal Cord; Substance P; Transplantation, Heterotopic

1994
Functional expression of adrenergic and opioid receptors in Xenopus oocytes: interaction between alpha 2- and beta 2-adrenergic receptors.
    Brain research. Molecular brain research, 1995, Volume: 28, Issue:1

    Topics: Adenylyl Cyclases; Animals; Brimonidine Tartrate; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cystic Fibrosis; Dose-Response Relationship, Drug; Isoproterenol; Models, Biological; Naloxone; Oocytes; Propranolol; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Receptors, Opioid; RNA, Messenger; Xenopus laevis

1995
Effect of morphine and abstinence syndrome on [3H]bromoxidine binding to alpha 2-adrenoceptors in rat brain.
    Neurochemical research, 1994, Volume: 19, Issue:4

    Topics: Adrenergic alpha-Agonists; Animals; Autoradiography; Brain; Brimonidine Tartrate; Drug Implants; Hippocampus; Male; Mesencephalon; Morphine; Morphine Dependence; Naloxone; Occipital Lobe; Organ Specificity; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Reference Values; Substance Withdrawal Syndrome; Superior Colliculi; Tritium

1994
The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation.
    Nature, 1993, Apr-01, Volume: 362, Issue:6419

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Electric Stimulation; Evoked Potentials; Excitatory Amino Acid Antagonists; Guinea Pigs; Hippocampus; In Vitro Techniques; Naloxone; Nerve Fibers; Pyramidal Tracts; Quinoxalines; Receptors, Opioid, kappa; Synapses

1993
Naloxone-induced potentiation of cardiac alpha-2 adrenoceptor-mediated depression of neurogenic tachycardia.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Depression, Chemical; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Heart; Male; Myocardium; Naloxone; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Tachycardia

1993
Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1993, Volume: 3, Issue:2

    Topics: Animals; Behavior, Animal; Dizocilpine Maleate; Glycine; Kynurenic Acid; Male; Mice; Morphine Dependence; Naloxone; Quinoxalines; Receptors, Amino Acid; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Substance Withdrawal Syndrome

1993
Changes in [3H]-UK 14304 binding to alpha 2-adrenoceptors in morphine-dependent guinea-pigs.
    British journal of pharmacology, 1995, Volume: 116, Issue:8

    Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cerebral Cortex; Dose-Response Relationship, Drug; Female; gamma-Aminobutyric Acid; Guinea Pigs; In Vitro Techniques; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Norepinephrine; Quinoxalines; Receptors, Adrenergic, alpha-2; Substance Withdrawal Syndrome; Synaptosomes; Tritium

1995
Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEA-1011 in the formalin test.
    Pharmacology, biochemistry, and behavior, 1996, Volume: 54, Issue:2

    Topics: Analgesia; Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Formaldehyde; Male; Mice; Mice, Inbred Strains; Morphine; Naloxone; Narcotic Antagonists; Pain Measurement; Quinoxalines; Stress, Psychological; Swimming

1996
The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Molecular pharmacology, 1996, Volume: 50, Issue:3

    Topics: Animals; Brimonidine Tartrate; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Methionine; Enkephalins; In Vitro Techniques; Kinetics; Locus Coeruleus; Male; Naloxone; Narcotics; Neurons; Nociceptin; Opioid Peptides; Peptide Fragments; Peptides; Potassium; Potassium Channels; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Somatostatin

1996
Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999, Nov-15, Volume: 19, Issue:22

    Topics: 2-Amino-5-phosphonovalerate; Animals; Calcium; Calcium Channels, L-Type; Cells, Cultured; Embryo, Mammalian; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Excitatory Amino Acid Antagonists; Hippocampus; Kinetics; Membrane Potentials; Naloxone; Neurons; Nimodipine; Oscillometry; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Tetrodotoxin; Time Factors

1999
Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Brain research, 2000, Mar-17, Volume: 859, Issue:1

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Cyclic GMP; Enzyme Inhibitors; Excitatory Amino Acids; Guanylate Cyclase; Locus Coeruleus; Male; Morphine; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome

2000
Failure of naloxone to reverse brimonidine-induced coma in an infant.
    The Journal of pediatrics, 2002, Volume: 140, Issue:4

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Coma; Dose-Response Relationship, Drug; Humans; Infant; Naloxone; Narcotic Antagonists; Quinoxalines; Treatment Failure

2002
Role of mu-opioid receptors in insulin release in the presence of inhibitory and excitatory secretagogues.
    European journal of pharmacology, 2002, Jul-12, Volume: 448, Issue:1

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Clonidine; Drug Interactions; Female; Glyburide; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Naloxone; Quinoxalines; Receptors, Opioid, mu; Somatostatin

2002
Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
    Neuroscience letters, 2003, Oct-02, Volume: 349, Issue:2

    Topics: Analgesics, Opioid; Animals; Avoidance Learning; Conditioning, Classical; Male; Morphine; Naloxone; Narcotic Antagonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome

2003
Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:7

    Topics: Animals; Behavior, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Microinjections; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Substance Withdrawal Syndrome; Synaptic Transmission; Ventral Tegmental Area; Weight Loss

2004
Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib.
    European journal of pharmacology, 2005, Apr-18, Volume: 513, Issue:1-2

    Topics: Analgesics; Animals; Apamin; Behavior, Animal; Charybdotoxin; Diclofenac; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formaldehyde; Glyburide; Guanylate Cyclase; Hindlimb; Injections, Spinal; Injections, Subcutaneous; Methiothepin; Naloxone; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organic Chemicals; Oxadiazoles; Pain; Pain Measurement; Quinoxalines; Rats; Rats, Wistar; Scorpion Venoms

2005
alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons.
    European journal of pharmacology, 2005, Jul-04, Volume: 517, Issue:1-2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amphetamines; Animals; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Citalopram; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Idazoxan; In Vitro Techniques; Locus Coeruleus; Male; Methiothepin; Naloxone; Narcotic Antagonists; Neurons; Norepinephrine; Oxazines; Piperazines; Piperidines; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes

2005
Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
    European journal of pharmacology, 2005, Dec-19, Volume: 527, Issue:1-3

    Topics: Animals; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Immunohistochemistry; Male; Microinjections; Morphine; Morphine Dependence; Naloxone; Nucleus Accumbens; Protein Isoforms; Proto-Oncogene Proteins c-fos; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Synaptic Transmission; Ventral Tegmental Area

2005
Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal-potentiated startle.
    Neuroscience, 2006, Volume: 139, Issue:4

    Topics: Acoustic Stimulation; Amygdala; Analysis of Variance; Animals; Behavior, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Fear; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Nucleus Accumbens; Opioid-Related Disorders; Quinoxalines; Rats; Rats, Sprague-Dawley; Reflex, Startle

2006
Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
    Anesthesia and analgesia, 2008, Volume: 106, Issue:3

    Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Guanylate Cyclase; Inflammation; Injections, Spinal; Male; Morphine; Naloxone; Narcotic Antagonists; Neutrophil Infiltration; Neutrophils; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Oxadiazoles; Peroxidase; Phosphodiesterase Inhibitors; Piperazines; Purines; Quinoxalines; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Sildenafil Citrate; Spinal Cord; Sulfones; Time Factors

2008
Teleantagonism: A pharmacodynamic property of the primary nociceptive neuron.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Dec-09, Volume: 105, Issue:49

    Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Dopamine; Drug Interactions; Enzyme Inhibitors; Indomethacin; Interleukin-1beta; Male; Morphine; Naloxone; Narcotic Antagonists; Nitric Oxide; Nociceptors; omega-N-Methylarginine; Oxadiazoles; Pain; Pyrrolidines; Quinoxalines; Rats; Rats, Wistar; Sensory Receptor Cells; Signal Transduction

2008
Brimonidine tartrate poisoning in children: frequency, trends, and use of naloxone as an antidote.
    Pediatrics, 2009, Volume: 123, Issue:2

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Child, Preschool; Humans; Infant; Naloxone; Poisoning; Quinoxalines; Retrospective Studies

2009
Tadalafil analgesia in experimental arthritis involves suppression of intra-articular TNF release.
    British journal of pharmacology, 2011, Volume: 164, Issue:2b

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arthralgia; Arthritis, Experimental; Carbolines; Chemokine CXCL1; Chemokines; Cyclic GMP; Guanylate Cyclase; Injections, Intra-Articular; Interleukin-1; Joints; Male; Naloxone; Narcotic Antagonists; Neutrophils; Nociception; Osteoarthritis; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar; Tadalafil; Tumor Necrosis Factor-alpha; Zymosan

2011
Mechanisms underlying the antinociceptive effect of mangiferin in the formalin test.
    European journal of pharmacology, 2013, Oct-15, Volume: 718, Issue:1-3

    Topics: Analgesics; Animals; Capsaicin; Formaldehyde; Glyburide; Male; Naloxone; Naltrexone; NG-Nitroarginine Methyl Ester; Nociception; Quinoxalines; Rats; Rats, Wistar; Serotonin; Xanthones

2013
Analysis of the mechanisms underlying the antinociceptive effect of epicatechin in diabetic rats.
    Life sciences, 2013, Oct-17, Volume: 93, Issue:17

    Topics: Analgesics; Animals; Biphenyl Compounds; Catechin; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Female; Glyburide; Hyperalgesia; Indazoles; Methiothepin; Naloxone; NG-Nitroarginine Methyl Ester; Oxadiazoles; Pain Measurement; Piperazines; Piperidones; Pyridines; Quinoxalines; Rats; Spiro Compounds

2013
Systemic toxicity from subcutaneous brimonidine injection successfully treated with naloxone.
    The American journal of emergency medicine, 2022, Volume: 59

    Topics: Adrenergic alpha-Agonists; Aged; Analgesics, Opioid; Bradycardia; Brimonidine Tartrate; Drug Overdose; Female; Glaucoma; Humans; Hypotension; Infant; Injections, Subcutaneous; Lethargy; Naloxone; Ophthalmic Solutions; Quinoxalines

2022